Pathogen inactivation in labile blood products transfusion safety and economic impact - Discussion

被引：0
|
作者：
Bourel, Michel
Caen, Jacques
Dirreimer, Guy
Vacheron, Andre
Sansonetti, Philippe
Michel-Briand, Yvon
机构：
来源：
BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE | 2006年 / 190卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：186 / 188
页数：3
相关论文
共 50 条
  • [1] Pathogen inactivation in labile blood products transfusion safety and economic impact
    Cazenave, Jean-Pierre
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2006, 190 (01): : 169 - 185
  • [2] Universal implementation of pathogen inactivation in labile blood products is a major step towards transfusion safety
    Cazenave, Jean-Pierre
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2010, 194 (09): : 1707 - 1719
  • [3] Pathogen inactivation of labile blood products
    Bopp, MKF
    Morell, A
    Indrak, K
    Parkkinen, J
    Mertens, H
    Mohr, H
    Colamartino, P
    Stanescu, I
    Oyonarte, S
    Delaney, FM
    Padilla, A
    TRANSFUSION MEDICINE, 2001, 11 (03) : 149 - 175
  • [4] Pathogen inactivation in labile blood products
    Naegelen, C.
    Isola, H.
    Dernis, D.
    Maurel, J. -P.
    Tardivel, R.
    Bois, S.
    Vignoli, C.
    Cazenave, J. -P.
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2009, 16 (02) : 179 - 189
  • [5] European view about pathogen inactivation in labile blood products
    Cazenave, J. P.
    VOX SANGUINIS, 2008, 95 : 8 - 8
  • [6] Pathogen Inactivation of Cellular Blood Products-An Additional Safety Layer in Transfusion Medicine
    Seltsam, Axel
    FRONTIERS IN MEDICINE, 2017, 4
  • [7] Pathogen inactivation of labile blood components
    Prowse, C
    Robinson, AE
    TRANSFUSION MEDICINE, 2001, 11 (03) : 147 - 147
  • [8] The Economic Impact of Pathogen Inactivation in the Blood Center and Hospital
    McCullough, J.
    Stowell, C.
    Gorlin, J. B.
    Ward, D.
    Goldfinger, D.
    Sandhu, H.
    Chrebtow, V.
    Stassinopoulos, A.
    TRANSFUSION, 2014, 54 : 57A - 57A
  • [9] Viral inactivation of labile blood products
    Follea, G
    Herve, P
    Andreu, G
    Bidet, JM
    Boudard, D
    Dazey, B
    Noel, L
    Piquet, Y
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 1996, 3 (02) : 113 - 123
  • [10] Pathogen inactivation in blood products
    Wainwright, M
    CURRENT MEDICINAL CHEMISTRY, 2002, 9 (01) : 127 - 143
12345